Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair

Journal of Orthopaedic Research

Volumn 31, Issue 1, 2013, Pages 164-172

  Wang, Xin Luan ^a,b   Xie, Xin Hui ^a,c   Zhang, Ge ^a   Chen, Shi Hui ^a   Yao, Dong ^a   He, Kai ^d   Wang, Xiao Hong ^d   Yao, Xin Sheng ^e   Leng, Yang ^f   Fung, Kwok Pui ^a   Leung, Kwok Sui ^a   Qin, Ling ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d TSINGHUA UNIVERSITY   (China)

^e JINAN UNIVERSITY   (China)

^f HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

angiogenesis; osteogenesis; PLGA TCP icaritin; porous scaffold; SAON

Indexed keywords

CALCIUM PHOSPHATE; ICARITIN; PHYTOESTROGEN; POLYGLACTIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE NECROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; ORTHOPEDIC SURGERY; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MARROW CELLS; CALCIUM PHOSPHATES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMORAL FRACTURES; FLAVONOIDS; FRACTURE HEALING; LACTIC ACID; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; OSTEONECROSIS; PHYTOESTROGENS; POLYGLYCOLIC ACID; RABBITS; RATS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84870251699     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22188     Document Type: Article

References (39)

1. Griffith JF, Antonio GE, Kumta SM, et al. 2005. Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology 235: 168-175.
2. Zhang G, Sheng H, He YX, et al. 2009. Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions. Arthritis Rheum 60: 2966-2977.
3. Moutos FT, Freed LE, Guilak F., 2007. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater 6: 162-167.
4. Kawate K, Yajima H, Ohgushi H, et al. 2006. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30: 960-962.
5. Place ES, Evans ND, Stevens MM., 2009. Complexity in biomaterials for tissue engineering. Nat Mater 8: 457-470.
6. He K, Wang X, Shekhar Madhunkar K, et al. 2009. Fabrication of a two-level tumor bone repair biomaterial based on a rapid prototyping technique. Biofabrication 1: 1-7.
7. Ehrenfried LM, Patel MH, Cameron RE., 2008. The effect of tri-calcium phosphate (TCP) addition on the degradation of polylactide-co-glycolide (PLGA). J Mater Sci Mater Med 19: 459-466.
8. Urist MR, Lietze A, Dawson E., 1984. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop Relat Res 187: 277-280.
9. Samee M, Kasugai S, Kondo H, et al. 2008. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 108: 18-31.
10. Lu X, Leng Y, Zhang X, et al. 2005. Comparative study of osteoconduction on micromachined and alkali-treated titanium alloy surfaces in vitro and in vivo. Biomaterials 26: 1793-1801.
11. Zhang G, Qin L, Shi YY., 2007. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res 22: 1072-1079.
12. Songlin P, Ge Z, Yixin H, et al. 2009. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone 45: 534-544.
13. Zhao J, Ohba S, Shinkai M, et al. 2008. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Biochem Biophys Res Commun 369: 444-448.
14. Zhang G, Qin L, Sheng H, et al. 2009. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 44: 345-356.
15. Chung BH, Kim JD, Kim CK, et al. 2008. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun 376: 404-408.
16. Zhang G, Wang XL, Sheng H, et al. 2009. Constitutional flavonoids derived from epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis not via direct action by themselves on potential cellular targets. PLoS ONE 4: e6419.
17. Bayliss PE, Bellavance KL, Whitehead GG, et al. 2006. Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat Chem Biol 2: 265-273.
18. Xie XH, Wang XL, Zhang G, et al. 2010. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin. Biomed Mater 5: 054109.
19. Wang X, Yan Y, Pan Y, et al. 2006. Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng 12: 83-90.
20. Yeung H, Qin L, Lee K, et al. 2005. Novel approach for quantification of porosity for biomaterial implants using microcomputed tomography (microCT). J Biomed Mater Res B Appl Biomater 75: 234-242.
21. Wang X, Zhen L, Zhang G, et al. 2011. Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei-an in vitro efficacy study. Phytomedicine 18: 868-872.
22. Raddatz D, Middel P, Bockemuhl M, et al. 2004. Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment Pharmacol Ther 19: 47-61.
23. Shimizu E, Matsuda-Honjyo Y, Samoto H, et al. 2004. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif. J Cell Biochem 91: 1183-1196.
24. Viereck V, Grundker C, Friess SC, et al. 2005. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. J Bone Miner Res 20: 2036-2043.
25. Zhang G, Guo B, Wu H, et al. 2012. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med 18: 307-314.
26. Qin L, Zhang G, Sheng H, et al. 2006. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone. Bone 39: 863-871.
27. Xie XH, Zhang G, He YX, et al. 2009. Promotion of tissue repair of steroid-associated osteonecrosis lesion in rabbits by using PLGA/TCP/icaritin composite biomaterials scaffold: an in vivo micro-computed tomography study. Bone 45: S107.
28. Yuan H, van Blitterswijk CA, de Groot K, et al. 2006. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng 12: 1607-1615.
29. Lutolf MP, Hubbell JA., 2005. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23: 47-55.
30. Hollister SJ., 2005. Porous scaffold design for tissue engineering. Nat Mater 4: 518-524.
31. Zalavras CG, Vartholomatos G, Dokou E, et al. 2004. Genetic background of osteonecrosis: associated with thrombophilic mutations ? Clin Orthop Relat Res 422: 251-255.
32. Yamamoto T, Hirano K, Tsutsui H, et al. 1995. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop Relat Res 316: 235-243.
33. Xie XH, Wang XL, Zhang G, et al. 2011. Impaired bone healing in rabbits with steroid-induced osteonecrosis. J Bone Joint Surg Br 93: 558-565.
34. Chen SH, Wang XL, Zheng LZ, et al. 2012 Comparative study on osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin-an in vitro efficacy study. Acta Biomater 8: 3128-3137.
35. Shore EM., 2011. Osteoinductive signals and heterotopic ossification. JBMR 26: 1166-1177.
36. Boyan BD, Weesner TC, Lohmann CH, et al. 2000. Porcine fetal enamel matrix derivative enhances bone formation induced by demineralized freeze dried bone allograft in vivo. J Periodontol 71: 1278-1286.
37. Choi IH, Chung CY, Cho TJ, et al. 2002. Angiogenesis and mineralization during distraction osteogenesis. J Korean Med Sci 17: 435-447.
38. Martinetti R, Dolcini L, Mangano C., 2005. Physical and chemical aspects of a new porous hydroxyapatite. Anal Bioanal Chem 381: 634-638.
39. Grellier M, Bordenave L, Amedee J., 2009. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27: 562-571.